Weiping Li

机构：Dalian Medical University, Second Affiliated Hospital of Dalian Medical University · ORCID：0000-0002-2352-7775

发表论文 33 篇 · 总被引 511 次 · h-index 12

代表论文

• Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4‐Akt‐ERK signalling by inhibiting EGR1‐dependent transcription (2019 · Phytotherapy Research · 被引 28)
• Combined Analysis of Surface Protein Profile and microRNA Expression Profile of Exosomes Derived from Brain Microvascular Endothelial Cells in Early Cerebral Ischemia (2021 · ACS Omega · 被引 27)
• A novel DPP ‐4 inhibitor Gramcyclin A attenuates cognitive deficits in APP / PS1 /tau triple transgenic mice via enhancing brain GLP ‐1‐dependent glucose uptake (2022 · Phytotherapy Research · 被引 25)
• Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice (2021 · Neuropharmacology · 被引 19)
• Activation of Swell1 in microglia suppresses neuroinflammation and reduces brain damage in ischemic stroke (2022 · Neurobiology of Disease · 被引 16)
• Silencing PAQR3 protects against oxygen-glucose deprivation/reperfusion-induced neuronal apoptosis via activation of PI3K/AKT signaling in PC12 cells (2020 · Life Sciences · 被引 16)